Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anacor Pharmaceuticals has named Geoffrey Parker as the new senior vice president and chief financial officer of the company, who will responsible for managing the company’s finance operations as well as its business development and investor relations functions.
Subscribe to our email newsletter
Parker worked as a consultant to Anacor Pharma from December 2009 to his current appointment as chief financial officer.
From July 2009 to July 2010, Parker served in a consulting capacity as the chief business officer of InteKrin Therapeutics, a biopharmaceutical company in Los Altos, California.
Anacor Pharma CEO David Perry said that as Anacor continues to explore the therapeutic and commercial potential of boron-based chemistry platform, Geoff’s deep knowledge of the biotechnology and pharmaceutical industry and experience in corporate finance, structuring and valuing transactions, strategic planning and executive management, make him an invaluable asset to our company.
Anacor is a biopharmaceutical company engaged in discovering, developing and commercialising small-molecule therapeutics derived from its chemistry platform.